DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Alphina Therapeutics, Inc.
Alphina Therapeutics, Inc.
Stage unknownNew Haven, CTBiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Feb 23, 2026Form D equity offering · $153,715 (form d sold) · 3 investorsFact SEC EDGAR Form D data sets (quarterly) · “Alphina Therapeutics, Inc. filed Form D: $153,715 sold of $10,000,000, Biotechnology”
Investors on record
1 edges
- Canaan Partners portfolio listing Fact canaan.com
People
2 officers, 4 directors
- Barbara J Fox Executive Officer/Director sec.gov
- Nicholas J Galli Executive Officer/Director sec.gov
- Kevin J Rakin Director Fact
- Colleen J Cuffaro Director Fact
- Matthew J Cohen Director Fact
- Ranjit J Bindra Director Fact
Timeline
1
- Mar 16, 2026Alphina Therapeutics, Inc. filed Form D: $153,715 sold of $10,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company
- Entity type: Corporation Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $153,715 Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $10.0M Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-02-23 Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 3 Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: option Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 55 Church Street, New Haven, CT, 06510 Mar 16, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: Canaan Partners Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Canaan Partners Sep 15, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)